Urologix (Urologix) Change In Inventory : $0.03 Mil (TTM As of Mar. 2015)

View and export this data going back to 1996. Start your Free Trial

What is Urologix Change In Inventory?

Urologix's change in inventory for the quarter that ended in Mar. 2015 was $0.01 Mil. It means Urologix's inventory declined by $0.01 Mil from Dec. 2014 to Mar. 2015 .

Urologix's change in inventory for the fiscal year that ended in Jun. 2014 was $0.27 Mil. It means Urologix's inventory declined by $0.27 Mil from Jun. 2013 to Jun. 2014 .

Urologix's Total Inventories for the quarter that ended in Mar. 2015 was $1.32 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Urologix's Days Inventory for the quarter that ended in Mar. 2015 was 81.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Urologix's Inventory Turnover for the quarter that ended in Mar. 2015 was 1.12.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Urologix's Inventory-to-Revenue for the quarter that ended in Mar. 2015 was 0.47.

Urologix Change In Inventory Historical Data

The historical data trend for Urologix's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Urologix Change In Inventory Chart

Urologix Annual Data

Trend

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Change In Inventory

Get a 7-Day Free Trial

-0.39

0.24

0.13

-0.63

0.27

Urologix Quarterly Data
	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15
Change In Inventory	Get a 7-Day Free Trial															0.06	-0.07	0.09	-	0.01

Urologix Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

Urologix (OTCPK:ULGX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Urologix's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.321	/	1.485	*	365 / 4
	=	81.17

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Urologix's Inventory Turnover for the quarter that ended in Mar. 2015 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.485	/	1.321
	=	1.12

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Urologix's Inventory to Revenue for the quarter that ended in Mar. 2015 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.321	/	2.796
	=	0.47

Urologix Change In Inventory Related Terms

Thank you for viewing the detailed overview of Urologix's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Urologix (Urologix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Urologix Inc (OTCPK:ULGX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

14405 21st Avenue North, Suite 110, Minneapolis, MN, USA, 55447

Website

http://www.urologix.com

Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.

Executives

Emery Sidney W Jr	director	C/O QUALIGEN THERAPEUTICS, INC., 2042 CORTE DEL NOGAL, CARLSBAD CA 92011
Patrick D Spangler	director	14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
Gregory Fluet	director, officer: CEO	14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
William M Moore	director
Guy C Jackson	director	C/O EPICEPT CORPORATION, 777 OLD SAW MILL ROAD, TARRYTOWN NY 10591
Daniel J Starks	director	ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Claude Tihon	officer: Chief Technology Officer
Bobby Ivan Griffin	director	1326 SPRING VALLEY RD GOLDEN VALLEY PA 55422
David A Montecalvo	officer: VP, Product Dev. & Operations	530 HERMAN O. WEST DRIVE, EXTON PA 19341
Susan Bartlett Foote	director	649 SUMMIT AVENUE, ST PAUL MN 55105